EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis

Athina Spiliopoulou iD, Andrii Iakovliev iD, Darren Plant iD, Megan Sutcliffe iD, Seema Sharma iD, Cankut Cubuk iD, Myles Lewis iD, Costantino Pitzalis iD, Anne Barton iD, Paul M McKeigue iD

Arthritis & Rheumatology · 2025-07 · 77 (7) · 817-826

DOI: 10.1002/art.43125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 16.03.2025. Verfasst von Athina Spiliopoulou und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Edinburgh, Edinburgh, Scotland. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Immune Checkpoint Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Barts Biomedical Research Centre, NIHR Manchester Biomedical Research Centre, Versus Arthritis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The sparse effector “omnigenic” hypothesis postulates that the polygenic effects of common single nucleotide polymorphisms (SNPs) on a typical complex trait are mediated by trans effects that coalesce on expression of a relatively sparse set of core genes. The objective of this study was to identify core genes for rheumatoid arthritis by testing for association of rheumatoid arthritis with genome‐wide aggregated trans effects (GATE) scores for expression of each gene as transcript in whole blood or as circulating protein levels.

Methods

GATE scores were calculated for 5,400 cases and 453,705 non‐cases of primary rheumatoid arthritis in UK Biobank participants of European ancestry.

Results

Testing for association with GATE scores identified 16 putative core genes for rheumatoid arthritis outside the HLA region, of which six— TP53BP1 , PDCD1 , TNFRSF14 , LAIR1 , LILRA4 , and IDO1 —were supported by Mendelian randomization analysis based on the marginal likelihood of the causal effect parameter. Five of these 16 genes were validated by a reported association of rheumatoid arthritis with SNPs within 200 kb of the transcription site, eight by association of the measured protein level with rheumatoid arthritis in UK Biobank, 10 by experimental perturbation in mouse models of inflammatory arthritis, and two— CTLA4 and PDCD1 —by evidence that drugs targeting the gene cause or ameliorate inflammatory arthritis in humans. Fourteen of these 16 genes are in pathways affecting immunity or inflammation, and six— CD5 , CTLA4 , TIGIT , LAIR1 , TNFRSF14 , and PDCD1 —encode receptors that have been characterized as immune checkpoints exploited by cancer cells to escape the immune response.

Conclusion

These results highlight the key role of immune checkpoints in rheumatoid arthritis and identify possible therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidImmune Checkpoint ProteinsHumansPolymorphism, Single NucleotideGenome-Wide Association StudyAnimalsFemaleMendelian Randomization AnalysisMaleMiceGenetic Predisposition to DiseaseReceptors, ImmunologicProgrammed Cell Death 1 ReceptorMiddle Aged

Substanzen

Immune Checkpoint ProteinsReceptors, ImmunologicProgrammed Cell Death 1 ReceptorPDCD1 protein, human

Autor:innen und Institutionen

  • University of Edinburgh, Edinburgh, Scotland.
  • University of Manchester and the National Institute for Health and Care Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Oxford Road, Manchester, United Kingdom.
  • University of Manchester, Manchester, United Kingdom.
  • Queen Mary University of London and Barts Health NHS Trust and NIHR Barts Biomedical Research Centre, London, United Kingdom.

ORCID-Profile: Athina Spiliopoulou, Andrii Iakovliev, Darren Plant, Megan Sutcliffe, Seema Sharma, Cankut Cubuk, Myles Lewis, Costantino Pitzalis, Anne Barton, Paul M McKeigue

Förderung

  • NIHR Barts Biomedical Research Centre
  • NIHR Manchester Biomedical Research Centre
  • Versus Arthritis
  • Academy of Medical Sciences
  • Medical Research Council
  • NIHR Barts Biomedical Research Centre, Queen Mary University of London
  • Manchester Biomedical Research Centre

Zitieren

APA

Spiliopoulou, A., Iakovliev, A., Plant, D., Sutcliffe, M., Sharma, S., Cubuk, C., Lewis, M., Pitzalis, C., Barton, A., & McKeigue, P. M. (2025). Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis. Arthritis & Rheumatology, 77(7), 817-826. https://doi.org/10.1002/art.43125

Vancouver

Spiliopoulou A, Iakovliev A, Plant D, Sutcliffe M, Sharma S, Cubuk C, et al. Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis. Arthritis & Rheumatology. 2025;77(7):817-826. doi:10.1002/art.43125

BibTeX
@article{Spiliopoulou2025,
  author = {Spiliopoulou, Athina and Iakovliev, Andrii and Plant, Darren and Sutcliffe, Megan and Sharma, Seema and Cubuk, Cankut and Lewis, Myles and Pitzalis, Costantino and Barton, Anne and McKeigue, Paul M},
  title = {Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {7},
  pages = {817--826},
  doi = {10.1002/art.43125}
}
Kostenlos starten →